YPI 008
Alternative Names: NM-401; YPI-008Latest Information Update: 05 Feb 2021
At a glance
- Originator Neuramedy; Yungjin Pharm Co
- Class Antiparkinsonians; Small molecules
- Mechanism of Action Alpha-synuclein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Parkinson's disease